{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:09:13Z","timestamp":1787015353954,"version":"build-2736575974"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1111\/jcpt.12170","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T05:18:14Z","timestamp":1399526294000},"page":"496-500","source":"Crossref","is-referenced-by-count":14,"title":["Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series"],"prefix":"10.1155","volume":"39","author":[{"given":"C. Y.","family":"Enderby","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Mayo Clinic; Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Soukup","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Mayo Clinic; Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Al Omari","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease; Mayo Clinic; Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zeiger","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine; Mayo Clinic; Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine; Mayo Clinic; Jacksonville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"10.1111\/jcpt.12170-BIB0001|jcpt12170-cit-0001","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/jcpt.12170-BIB0002|jcpt12170-cit-0002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0003|jcpt12170-cit-0003","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/529552","article-title":"Bloodstream infections in patients given treatment with intravenous prostanoids","volume":"29","author":"Kallen","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/jcpt.12170-BIB0004|jcpt12170-cit-0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1378\/chest.11-0245","article-title":"The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension","volume":"141","author":"Rich","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jcpt.12170-BIB0005|jcpt12170-cit-0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.mayocp.2012.05.014","article-title":"Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from REVEAL REGISTRY\u00ae","volume":"87","author":"Kitterman","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/jcpt.12170-BIB0006|jcpt12170-cit-0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1378\/chest.126.1.90","article-title":"Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"key":"10.1111\/jcpt.12170-BIB0007|jcpt12170-cit-0007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil","volume":"28","author":"Barst","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/jcpt.12170-BIB0008|jcpt12170-cit-0008","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2006.06.062","article-title":"Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies","volume":"48","author":"Voswinckel","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0009|jcpt12170-cit-0009","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2006.05.070","article-title":"Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension","volume":"48","author":"Channick","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0010|jcpt12170-cit-0010","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0011|jcpt12170-cit-0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005344-200408000-00010","article-title":"Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers","volume":"44","author":"Laliberte","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/jcpt.12170-BIB0012|jcpt12170-cit-0012","volume-title":"Remodulin (treprostinil) [package insert]","year":"2011"},{"key":"10.1111\/jcpt.12170-BIB0013|jcpt12170-cit-0013","volume-title":"Tyvaso (inhaled treprostinil) [package insert]","year":"2011"},{"key":"10.1111\/jcpt.12170-BIB0014|jcpt12170-cit-0014","volume-title":"Flolan (epoprostenol) [package insert]","year":"2011"},{"key":"10.1111\/jcpt.12170-BIB0015|jcpt12170-cit-0015","volume-title":"Veletri (epoprostenol) [package insert]","year":"2012"},{"key":"10.1111\/jcpt.12170-BIB0016|jcpt12170-cit-0016","volume-title":"Ventavis (iloprost) [package insert]","year":"2011"},{"key":"10.1111\/jcpt.12170-BIB0017|jcpt12170-cit-0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1755-5922.12008","article-title":"Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension","volume":"31","author":"Bourge","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/jcpt.12170-BIB0018|jcpt12170-cit-0018","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","article-title":"Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension","volume":"172","author":"Gomberg-Maitland","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/jcpt.12170-BIB0019|jcpt12170-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0b013e31802b3184","article-title":"Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension","volume":"49","author":"Sitbon","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/jcpt.12170-BIB0020|jcpt12170-cit-0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjcard.2006.09.119","article-title":"Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil","volume":"99","author":"Ivy","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0021|jcpt12170-cit-0021","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1378\/chest.06-2118","article-title":"Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial","volume":"132","author":"Rubenfire","year":"2007","journal-title":"Chest"},{"key":"10.1111\/jcpt.12170-BIB0022|jcpt12170-cit-0022","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.amjcard.2012.07.012","article-title":"Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension","volume":"110","author":"de Jesus Perez","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1111\/jcpt.12170-BIB0023|jcpt12170-cit-0023","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2011.08.019","article-title":"Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension","volume":"30","author":"Benza","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jcpt.12170-BIB0024|jcpt12170-cit-0024","first-page":"170","article-title":"Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension: seven sites, United States, 2003-2006","volume":"2","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/jcpt.12170-BIB0025|jcpt12170-cit-0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","volume":"160","author":"Doran","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1111\/jcpt.12170-BIB0026|jcpt12170-cit-0026","volume-title":"ClinicalTrials.gov [Internet]","author":"Los Angeles Biomedical Research Institute; United Therapeutics","year":"2000"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12170","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12170\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:05:26Z","timestamp":1671800726000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12170","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}